Source: Pharamceutical Technology

ADVANZ PHARMA: UK MHRA approves Advanz Pharma antibiotic for complex infections

The UK MHRA has approved Advanz Pharma's combined antibiotic, cefepime/enmetazobactam, to treat complicated infections.

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
500-1.0K
Steffen Wagner's photo - CEO of ADVANZ PHARMA

CEO

Steffen Wagner

CEO Approval Rating

82/100

Read more